ANTI NUCLEAR ANTIBODY FACTOR ANA ANF IFA HEP-2 END POINT TITRE Test
At DNA Labs UAE, we offer the ANTI NUCLEAR ANTIBODY FACTOR ANA ANF IFA HEP-2 END POINT TITRE Test to help diagnose autoimmune disorders. This laboratory test detects the presence of antibodies against components of the cell nucleus in a patient’s blood.
Test Components
Price: 470.0 AED
Sample Condition: 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred.
Report Delivery
Sample Daily by 11 am; Report Next Day
Method
Immunofluorescence Assay (Hep-2 Substrate)
Test Type
Autoimmune disorders
Doctor
Rheumatologist, Chest Physician, Physician
Test Department
IMMUNOPATHOLOGY
Pre Test Information
Overnight fasting is preferred.
Test Details
The Anti Nuclear Antibody / Factor (ANA / ANF) IFA (HEP-2) End Point Titre Test is a laboratory test used to detect the presence of antibodies against components of the cell nucleus in a patient’s blood. It is primarily used to diagnose autoimmune diseases such as systemic lupus erythematosus (SLE) and Sjgren’s syndrome.
The test involves exposing a patient’s blood sample to a specific type of human cell line called HEP-2 cells, which have a high concentration of nuclear antigens. If the patient has antibodies against these nuclear antigens, they will bind to the HEP-2 cells. The cells are then stained with a fluorescent dye, and a microscope is used to examine the cells for the presence of fluorescent patterns.
The end point titre refers to the highest dilution of the patient’s blood sample that still shows a positive reaction. A higher titre indicates a higher concentration of antibodies in the blood, which may be indicative of a more severe autoimmune disease.
It is important to note that a positive ANA test does not necessarily mean that a person has an autoimmune disease. Further testing and evaluation by a healthcare professional are usually required to confirm a diagnosis.
| Test Name | ANTI NUCLEAR ANTIBODY FACTOR ANA ANF IFA HEP-2 END POINT TITRE Test |
|---|---|
| Components | |
| Price | 470.0 AED |
| Sample Condition | 2 mL (1 mL min.) serum from 1 SST. Ship refrigerated or frozen. Overnight fasting is preferred. |
| Report Delivery | Sample Daily by 11 am; Report Next Day |
| Method | Immunofluorescence Assay (Hep-2 Substrate) |
| Test type | Autoimmune disorders |
| Doctor | Rheumatologist, Chest Physician, Physician |
| Test Department: | IMMUNOPATHOLOGY |
| Pre Test Information | Overnight fasting is preferred. |
| Test Details |
The Anti Nuclear Antibody / Factor (ANA / ANF) IFA (HEP-2) End Point Titre Test is a laboratory test used to detect the presence of antibodies against components of the cell nucleus in a patient’s blood. It is primarily used to diagnose autoimmune diseases such as systemic lupus erythematosus (SLE) and Sjgren’s syndrome. The test involves exposing a patient’s blood sample to a specific type of human cell line called HEP-2 cells, which have a high concentration of nuclear antigens. If the patient has antibodies against these nuclear antigens, they will bind to the HEP-2 cells. The cells are then stained with a fluorescent dye, and a microscope is used to examine the cells for the presence of fluorescent patterns. The end point titre refers to the highest dilution of the patient’s blood sample that still shows a positive reaction. A higher titre indicates a higher concentration of antibodies in the blood, which may be indicative of a more severe autoimmune disease. It is important to note that a positive ANA test does not necessarily mean that a person has an autoimmune disease. Further testing and evaluation by a healthcare professional are usually required to confirm a diagnosis. |
